Lv1
50 积分 2026-05-27 加入
Comparative Outcomes of Teprotumumab and Tocilizumab in Thyroid Eye Disease: The First Retrospective Study from the United Arab Emirates and Gulf Region of the Middle East
2个月前
已完结
Corticosteroids Versus Teprotumumab for the Treatment of Thyroid Eye Disease. Does Either Mitigate the Need for Additional Treatments?
2个月前
已完结
Tocilizumab in Active, Moderate-to-Severe, Glucocorticoid-Resistant Thyroid Eye Disease: An Open-Label Prospective Study in Two Independent Cohorts
2个月前
已完结
Global trends in thyroid cancer 1990–2021: an analysis based on the GBD 2021
2个月前
已关闭
The Characteristics of Iodine Nutrition Status in China After 20 Years of Universal Salt Iodization: An Epidemiology Study Covering 31 Provinces
3个月前
已完结
Cigarette Smoking Drives Thyroid Eye Disease Progression via RAGE Signaling Activation
3个月前
已完结
皖公网安备34019202002308
